Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report

A man with severe hemophilia A (HA) without factor VIII (FVIII) inhibitors was admitted for total arthroplasty of his elbow. The patient was being treated with emicizumab, with his last administration given 8 days before surgery. Preoperatively, he received a bolus of 4000 international units (IU) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillaume, Louise, van Dievoet, Marie-Astrid, Lambert, Catherine, Hermans, Cedric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404639/
https://www.ncbi.nlm.nih.gov/pubmed/34471511
http://dx.doi.org/10.1177/20406207211040345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404639/
https://www.ncbi.nlm.nih.gov/pubmed/34471511
http://dx.doi.org/10.1177/20406207211040345

Ejemplares similares